Could This Canopy Growth (TSX:WEED) Spin-Off Be a Great Buy?

Canopy Rivers Inc. (TSXV:RIV) has an interesting business strategy and could benefit substantially from the growing marijuana market. But is it a buy right now?

edit Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.

Image source: Getty Images

Canopy Growth is the largest marijuana company in the world by market cap. The firm dominates the Canadian market and racks up revenues that outperform that of any of its peers. Canopy Growth may be one of the better investment options for those looking to profit from the marijuana craze, but one of the firm’s subsidiaries, namely Canopy Rivers (TSXV:RIV), could be an interesting option to consider as well. 

Canopy Rivers’s business model

First, it’s important to get one thing out of the way: Canopy Rivers is a separate entity from Canopy Growth. The former of these was originally founded in 2017 with the goal to facilitate Canopy Growth’s progress within the marijuana sector by pursuing interesting investing opportunities. Last year, Rivers acquired its own stock listing, and given how different its operations are from that of its parent company, its prospects ought to be analyzed on their own merits. 

Canopy Rivers’s portfolio includes more than 18 companies, and the list is growing. What is striking about its portfolio, though, is the diversity of the companies within it. It includes firms that specialize in hemp and CBD extraction, retail distributors of cannabis products, pharmaceutical-focused companies, cannabis beauty products, cannabis-infused beverage products, and many more. 

Canopy Rivers’s business strategy has an advantage over many firms within the marijuana market since its success (or failure) isn’t tied to a specific segment of the industry. Instead, a bet on Canopy Rivers essentially allows investors to have a hand in every broad segment of the marijuana market. As the sector grows, as it is projected to do at a fast pace, Rivers could post increasingly strong revenues and earnings if the companies under its umbrella are successful. Of course, that is a big if, but the strategy is definitely enticing. 

Canopy Rivers has another advantage over similar companies in its industry: namely its partnership with Canopy Growth. Small cannabis ventures looking for funds know they will likely get much more than that with Rivers; they will also profit from a partnership, albeit not a direct one, with the largest pot company in the world. Thus, Rivers will likely continue to attract potential ventures, which is good news for the company. 

Is it a buy?

There is no denying that Canopy Rivers’s strategy carries a lot of risk. Venture capitalism is generally a high-risk, high-reward business in any industry, but in one as nascent as the marijuana sector, the risks seem even greater. Rivers could end up being a huge success provided it makes the right investments, but much less optimistic scenarios seem just as plausible at this point. In short, it may be a bit too early to pull the trigger on Canopy Rivers. 

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Prosper Bakiny has no position in any of the stocks mentioned.  

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »